DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX (Q2019366): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in fr, and other parts: Adding French translations) |
(Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations) |
||||||||||||||
| label / nl | label / nl | ||||||||||||||
ONTWIKKELING VAN EEN PLATFORM VOOR MUTANOMA-IDENTIFICATIE EN GEPERSONALISEERDE VACCINATIE BIJ KANKERPATIËNTEN — PRECIVAX | |||||||||||||||
| Property / summary | |||||||||||||||
BIOTECHNOLOGIE (Dutch) | |||||||||||||||
| Property / summary: BIOTECHNOLOGIE (Dutch) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: BIOTECHNOLOGIE (Dutch) / qualifier | |||||||||||||||
point in time: 22 December 2021
| |||||||||||||||
Revision as of 21:08, 22 December 2021
Project Q2019366 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX |
Project Q2019366 in Italy |
Statements
986,675.87 Euro
0 references
1,329,656.71 Euro
0 references
74.21 percent
0 references
1 November 2016
0 references
31 December 2018
0 references
NOUSCOM SOCIETA' A RESPONSABILITA' LIMITATA
0 references
BIOTECNOLOGIE (Italian)
0 references
BIOTECHNOLOGY (English)
0 references
Identifiers
B88I17000390008
0 references